EXI1:XETRA:XETRA-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 141.86

Change

-2.34 (-1.62)%

Market Cap

USD 0.37B

Volume

1.58K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.09 (+0.17%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.03 (+0.19%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.15%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.03 (+0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.25%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.18 (+0.83%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.04 (+0.09%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.34 (-0.43%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.01 (-0.02%)

USD 79.79B

ETFs Containing EXI1:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.71% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.71% 53% F 55% F
Trailing 12 Months  
Capital Gain 15.18% 59% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.18% 58% F 59% D-
Trailing 5 Years  
Capital Gain 47.59% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.59% 69% C- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.86% 68% D+ 66% D+
Dividend Return 9.17% 68% D+ 64% D
Total Return 0.31% 30% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 11.73% 53% F 62% D
Risk Adjusted Return 78.15% 81% B- 83% B
Market Capitalization 0.37B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.